259 related articles for article (PubMed ID: 8974708)
1. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
Barz D; Gatzka E; Kollmorgen I
Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
[TBL] [Abstract][Full Text] [Related]
2. [Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].
Barz D; Staack D; Lehmann R; Stange K; Schnurstein K
Beitr Infusionsther Transfusionsmed; 1996; 33():30-4. PubMed ID: 8974705
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
Kuntz BM; Wollenhaupt HJ; Brüster HT
Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
[TBL] [Abstract][Full Text] [Related]
5. A study of platelet alloantibody in multiply-transfused haematology patients.
Linn YC; Prakash P; Ong YW
Ann Acad Med Singap; 1995 Mar; 24(2):305-11. PubMed ID: 7653976
[TBL] [Abstract][Full Text] [Related]
6. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
7. A modified rapid monoclonal antibody-specific immobilization of platelet antigen assay for the detection of human platelet antigen (HPA) antibodies: a multicentre evaluation.
Campbell K; Rishi K; Howkins G; Gilby D; Mushens R; Ghevaert C; Metcalfe P; Ouwehand WH; Lucas G
Vox Sang; 2007 Nov; 93(4):289-97. PubMed ID: 18070271
[TBL] [Abstract][Full Text] [Related]
8. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusions in 75 patients undergoing autologous bone marrow transplantation.
Lund BV; Madsen M
Transplant Proc; 1994 Jun; 26(3):1825. PubMed ID: 8030156
[No Abstract] [Full Text] [Related]
10. Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching.
Köhler M; Dittmann J; Legler TJ; Lynen R; Humpe A; Riggert J; Neumeyer H; Pies A; Panzer S; Mayr WR
Transfusion; 1996 Mar; 36(3):250-5. PubMed ID: 8604511
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
[TBL] [Abstract][Full Text] [Related]
12. Refractory response to platelet transfusion therapy.
Eisenberg S
J Infus Nurs; 2010; 33(2):89-97. PubMed ID: 20228646
[TBL] [Abstract][Full Text] [Related]
13. [Immunologic aspects of thrombocyte transfusion].
Mueller-Eckhardt C
Beitr Infusionsther; 1991; 28():132-41. PubMed ID: 1725611
[TBL] [Abstract][Full Text] [Related]
14. Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
Arber C; Bertrand G; Halter J; Boehlen F; Kaplan C; Gratwohl A
Br J Haematol; 2007 Oct; 139(1):159-61. PubMed ID: 17854320
[No Abstract] [Full Text] [Related]
15. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
16. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
[TBL] [Abstract][Full Text] [Related]
17. Immunological consequences of blood transfusions.
Claas FH; Lagaay EL; van Rood JJ
Schweiz Med Wochenschr Suppl; 1991; 43():70-2. PubMed ID: 1688196
[No Abstract] [Full Text] [Related]
18. Strategies for managing refractoriness to platelet transfusions.
Dan ME; Schiffer CA
Curr Hematol Rep; 2003 Mar; 2(2):158-64. PubMed ID: 12901147
[TBL] [Abstract][Full Text] [Related]
19. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
[TBL] [Abstract][Full Text] [Related]
20. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
Lo SC; Chang JS; Lin SW; Lin DT
Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
